Frontier Capital Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Frontier Capital Management's DYN Position: Q3 2026 in Review
Frontier Capital Management reduced its Dyne Therapeutics (DYN) stake by 79% in Q3 2026, selling an estimated $15.8M and leaving 187,380 shares worth $3.02M. The position accounts for 0.03% of the portfolio, ranked #278.
Frontier Capital Management first reported a position in DYN in Q4 2024 and has held it in 8 quarters since. The position peaked at $22.3M in Q4 2025. 266 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Frontier Capital Management held 187,380 shares of Dyne Therapeutics worth $3.02M as of Q3 2026.
- Frontier Capital Management sold 686,758 Dyne Therapeutics shares in Q3 2026, an estimated $15.8M.
- Dyne Therapeutics made up 0.03% of Frontier Capital Management's portfolio in Q3 2026, its #278 holding.
- Frontier Capital Management first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 8 quarters since.
- Frontier Capital Management's Dyne Therapeutics position peaked at $22.3M in Q4 2025.
- 266 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Frontier Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.